The Administrative Regulations of the People’s Republic of China on Human Genetic Resources (the “Regulations”), promulgated by China’s State Council, have been in effect for almost three years. As the administrative...more
3/25/2022
/ Benefit Sharing Agreements ,
China ,
Clinical Trials ,
Collaboration ,
Comment Period ,
Enforcement ,
Filing Requirements ,
Foreign Persons ,
Genetic Materials ,
Penalties ,
Proposed Rules ,
Public Comment ,
Reporting Requirements ,
Rulemaking Process ,
Scientific Research
On November 2, 2021, China’s Ministry of Commerce (MOFCOM) published a notice of an update to China’s Catalog of Technologies the Import of Which is Prohibited or Restricted (the “Catalog”). This is the first time the Catalog...more